Trial intelligence / Profile preview

IVIg in Relapsing ANCA-Associated Vasculitis

NCT00307658Phase 3Terminated

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Mar 2001
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of intravenous immunoglobulin G in granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2001; status: terminated.

02

Drugs

intravenous immunoglobulin G
03

Conditions

granulomatosis with polyangiitis (GPA)microscopic polyangiitis (MPA)eosinophilic granulomatosis with polyangiitis (EGPA)

Beyond the preview

Go deeper on NCT00307658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00307658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call